Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF Cells for Small Rotator Cuff Tears
NCT05264922Phase 2Withdrawn
- Sponsor
- AdventHealth
- Start
- Jan 2022
- Primary completion
- Jul 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose stromal vascular fraction in rotator cuff tear, sponsored by AdventHealth. Planned start Jan 2022; status: withdrawn.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT05264922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05264922.